Phenotypic and molecular characterization of quinolone resistance in Mycobacterium abscessus subsp bolletii recovered from postsurgical infections

作者：Nogueira de Moura Vinicius Calado; da Silva Marlei Gomes; Gomes Karen Machado; Coelho Fabrice Santana; Mello Sampaio Jorge Luiz; de Queiroz Mello Fernanda Carvalho; da Silva Lourenco Maria Cristina; Teixeira Amorim Efigenia de Lourdes; Duarte Rafael Silva^*

来源：Journal of Medical Microbiology, 2012, 61(1): 115-125.

DOI：10.1099/jmm.0.034942-0

Several outbreaks of infections caused by rapidly growing mycobacteria (RGM) were reported in many Brazilian states (2032 notified cases) from 2004 to 2010. Most of the confirmed cases were mainly associated with Mycobacterium massiliense (recently renamed as Mycobacterium abscessus subsp. bolletii) BRA100 clone, recovered from patients who had undergone invasive procedures in which medical instruments had not been properly sterilized and/or disinfected. Since quinolones have been an option for the treatment of general RGM infections and have been suggested for therapeutic schemes for these outbreaks, we evaluated the in vitro activities of all generations of quinolones for clinical and reference RGM by broth microdilution, and analysed the peptide sequences of the quinolone resistance determining regions (ORDRs) of GyrA and GyrE after DNA sequencing followed by amino acid translation. Fifty-four isolates of M. abscessus subsp. bolletii, including clone BRA100, recovered in different states of Brazil, and 19 reference: strains of RGM species were characterized. All 54 M. abscessus subsp. bolletii isolates were resistant to all generations of quinolones and showed the same amino acids in the ORDRs, including the Ala-83 in GyrA, and Arg-447 and Asp-464 in GyrB, described as being responsible: for an intrinsic low level of resistance to quinolones in mycobacteria. However, other RGM species showed distinct susceptibilities to this class of antimicrobials and patterns of mutations contrary to what has been traditionally defined, suggesting that other mechanisms of resistance, different from gyrA or gyrB mutations, may also be involved in resistance to high levels of quinolones.

• 出版日期2012-1